Treatment of hypertension following endotracheal intubation A study comparing the efficacy of labetalol, practolol and placebo by Maharaj, R. J. et al.
The family histories ofour patients have not revealed a genetic
predisposition to the disease. In Europe or North America these
patients might have been diagnosed as having MS. It is recog-
nized that a small proportion of patients with MS may lack a
history of remission and relapse; however, it is unlikely that the
patients in this series have MS, especially in view of the fact that
the more common forms of MS are virtually unknown among
South African Blacks.
Unexplained neurological disorders affecting the legs have
been described in many tropical and subtropical countries.'
Table V lists the main features of important examples of these.
They fall into two groups: the spastic group (like the present
series of cases) and an ataxic group. Where likely causes have
been identified these are either malnutrition or toxic dietary
factors.
The patients in our series did not show clinical stigmata of
malnutrition. The normal Vitamin BI2 and folate levels support
this conclusion. The evidence seems to point more towards a
toxic dietary factor. The occurrence of the syndrome in a single
population group and its preponderance among those of rural
origin with traditional dietary habits lends weight to this
hypothesis. The clinical features of these patients from Natal
resemble those of the patients with lathyrism in central India. ;
Lathyrism is caused by a toxic substance contained in the seeds
of Larhyrus sari7'lIs, which is used as a staple diet, especially in
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times of famine. This legume is not grown for human consump-
tion in lata!. It is, however, possible that similar toxins may
occur in local foodstuffs or in herbs used for medicinal purposes.
In the final analysis, therefore, this syndrome of unexplained
paraplegia appears to be a distinct nosological entity. Its aetio-
logy may be multifactorial but, on circumstantial evidence, one
or more toxic dietary factors are most prominent among the
suspected causes.
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Treatment of hypertension following
endotracheal intubation
A study comparing the efficacy of labetalol, practolol and placebo




Labetalol, a new adrenergic receptor antagonist,
has both a- and B-blocking properties. Intravenous
labetalol (0,25 and 0,5 mg/kg), practolol (0,4 mg/kg)
and saline (1 ml), injected prior to anaesthesia, were
compared with respect to their effect on the haemo-
dynamic consequences of direct laryngoscopy fol-
lowed by the passage of an endotracheal tube.
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When compared with intravenous saline injec-
tion, both labetalol and practolol obtunded the
tachycardia induced by endotracheal intubation.
The higher dose of labetalol was more effective in
reducing the hypertensive response than the lower
dose of practolol. However, none of the regimens·
completely abolished the adverse haemodynamic
consequences of laryngotracheal, manipUlations.
S Air Med J 1983; 63: 69H,94.
The acute hypertensive effects oflaryngoscopy and endotracheal
intubation af~probably of little consequence in the young,
healthy, normotensive patient. However, the sudden rise in sys-
tolic blood pressure consequent on endotracheal intubation
increases the afterload on the heart and may precipitate acute left
ventricular failure or a cerebrovascular accident in susceptible
subjects. I .2 A rise in heart rate reduces left ventricular filling
time, and, together with the rise in systolic blood pressure,
increases the rate pressure product, thus compromising myocar-
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dial conrractility and oxygen upply. In patienrs with pre-
existing hypertension, myocardial ischaemia or cerebrovascular
disease, these haemodynamic changes are therefore porenrially
harmful.
The adverse cardiovascular changes induced by routine laryn-
goscopy and passage of an endotracheal tube are thought to be
due to reflex sympatho-adrenal stimulation.' Several pharmaco-
logical agenrs have been investigated in an effort to prevenr these
detrimenral responses; the agents include atropine,· phentola-
mine,· halothane,' adrenergic receptor antagonists,2 droperidol 6
and topical' and inrravenous lignocaine.
Thi study was planned to elucidate the effects of labetalol, a
R-adrenergic anragonist with weak a-adrenergic antagonist
properties, on the haemodynamic effects of laryngo copy and
endotracheal intubation. Labetalol was used in two dosages,
their efficacy being compared with that of a single dose of
practolol and saline placebo.
every minute for 7 minutes after intubation, the need to use
halogenated inhalation agents to maintain anaesthesia in some
patients makes the valur.s obtained after 3 minutes not strictly
comparable, as various concentrations of halothane were used.
Only measurements obtained up to 3 minutes after intubation
were therefore considered comparable for analysis.
Systolic arterial blood pressure (Fig. I). The systolic
blood pressure in all four groups were similar until endotracheal
intubation. In the group which received the higher dose of
labetalol the rise was similar to that in the other three groups. At
1,2 and 3 minutes, the patients receiving practolol had a higher
systolic pressure than the other three groups. The maximum
arterial pressure on intubation was highest in the contrpl group.
The difference between the high-dose labetalol group and the
placebo group was significanr (P < 0,04) I minute afte.r intuba-
tion. The same P value applied to the mean arterial pr·essure.
'80
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Fig. 1. Changes in systolic blood pressure. Key (same for Figs
1-4): 0 = practolol 0,4 mg/kg; ... =saline 1 ml;. = labetalol 0,25
mg/kg; • = labetalol 0,5 mg/kg; PO = pre-drug; 02 =2 minutes
after injecting drug; 05 = 5 minutes after injecting drug; PI =
post-induction; PS = post-suxamethonium; EO = at intubation;
E1 =1 minute after intubation; E2 =2 minutes after intubation; E3
= 3 minutes after intubation.
Diastolic pressure (Fig. 2). Similar diastolic pressures were
recorded before induction ofanaesthesia, with a tendency for the
high-dose labetalol group to have a lower diastolic blood pres-
ure than the placebo group at injection of suxamethonium. On
endotracheal intubation, the diastolic pressure was highest in the
placebo group; it was significantly higher than that in the high-
dose labetalol group (P = 0,05). At I, 2 and 3 minutes the
diastolic pressure was higher in the pranolol group than in the
other groups, the difference at 2 minutes proving significantly






Sixty healthy patienrs (American Society of Anesthesiologists
categories I - I I) scheduled for elective surgery were studied with
their informed consent. The tudy was approved by the Ethic
and Standards Subcommittee of the Faculty of 1\ledicine, nt-
\'ersity of atal. All patienrs received premedication with
lorazepam 2 mg given sub lingually approximately 2 hours before
induction of anaesthesia.
On arrival in the operating theatre, the leads of an ECG
monitor (Portascope; Mennen Greatbatch) were attached to
each patient. The cuff of an automatic arterial blood pressure
recording de\'ice (Sentry; Automated Screening Devices) for
determination of the systolic, diastolic and mean arterial blood
pres ure and the heart rate encircled the patient's arm. Baseline
recordings of the heart rate and the systolic, diastolic and mean
blood pre sures were made. If the initial blood pressure reading
\\'as higher than that obtained at the pre-anaesthetic examina-
tion, the patient was allowed to adju t to the surroundings, and
mea urements were repeated after 5 minutes. All patients with a
mean arterial pressure higher than 100 mmHg or 100\'er than 80
mmHg were excluded from the trial.
The patients then received labetalol 0,5 mg/kg (group I),
practolol 0,4 mg/kg (group II), saline (group Ill) or labetalol
0,25 mg/kg (group IV) intravenously on a random basis.
Arterial blood pressure and heart rate were determined 2
minute and 5 minutes after injection of the drug or placebo,
during which time the patient was pre-oxygenated with a Magill
anaesthetic breathing system.
Anaesthesia was induced with a 2,5% solution of thiopenrone 4
mg/kg injected at a rate of approximately 5 mg/s. Heart rate and
blood pressures were then recorded again. Muscle relaxation was
produced by the injection of uxamethonium I mg/kg. Further
readings were taken before visualization of the larynx and pas-
sage of an endotracheal tube via the mouth. Arterial blood pres-
sure and heart rate were recorded at the time of intubation and
subsequently every minute for up to 7 minutes. Anaesthesia was
maintained with nitrous oxide 60% in oxygen given through the
endotracheal tube, using a circle absorber throughout this
period. The subsequent anaesthetic management varied accord-
ing to surgical requirements.
Statistical analysis was performed by computer. Two-tailed
probability value equal to or less than 0,05 were regarded a
significant.
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Although heart rate and blood pressure readings were taken Fig. 2. Changes in diastolic blood pressure.
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Fig. 6. Changes in diastolic blood pressure expressed as percen-
tage change from pre-drug baseline value.
Fig. 5. Changes in systolic blood pressure expressed as percen-
tage change from pre-drug baseline value. Key (same for Figs
5-8): 0 = practolol 0,4 mg/kg; • = saline 1 ml; ~ = labetalol 0,25



















Fig_ 3. Changes in mean blood pressure.
Mean blood pressure (Fig. 3). Changes in mean blood
pressure are shown in Fig. 3.
Heart rate (Fig. 4). In all four groups, the heart rate
increased initially ro the same level following inducrion and after
the administration of suxamethonium. However, after laryngo-
scopy and endorracheal intubation the placebo group had a
higher heart rate than either the patients who received pracrolol
(group 11) or those who received labetalol (groups I and IV), the
difference attaining statistical significance at the P = 0,04 and
P =O,OOlle\-els respectively. No statistically important differen-
ces were noted between groups I, 11 and Ill.
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Fig. 4. Changes in heart rate.
Fig. 7. Changes in mean blood pressure expressed as percentage
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Percentage changes in blood pressure from baseline
values (Figs 5, 6 and 7). In its higher dose (0,5 mg/kg) labetalol
produced a significant decrease in blood pressure 2 minutes after
injection of the drug. While there is an impression that blood
pressure in those patients pretreated with the higher dose of
labetalol tended ro have a lower pressor response ro intubation,
these values failed ro achieve statistical significance when com-
pared with the placebo group. An interesting finding is that those
patients pretreated with practolol had a slower rate of decline in
blood pressure rowards normal than the other groups.
Percentage changes from baseline heart rate (Fig. 8).
The high-dose labetalol group had a significantly greater reduc-
tion in heart rate 2 minutes after injection of the drug (P = 0,0 I).
This effect persisted at the 5th minute after injection. At this
stage the low-dose labetalol group also had a significantly lower
pulse rate (P = 0,01). Immediately after intubation the rise in
heart rate was lowest in the two groups pretreated with labetalol.
The pracrolol group also had a lower heart rate at this point, but
the values failed ro reach statistical significance (P = 0,08). The
maximal rise in all three treated groups was lower than that in the
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Discussion
Fig. 8. Changes in heart rate expressed as percentage change
from pre-drug baseline value.
untreated group. Values in the low-dose labetalol group arrained
statistical significance (P = 0,03) when compared with those in
the placebo group.
No cardiac dy rhythmias were encountered in this series, and
anaesthesia was uneventful in all the patients.
Significant rises in arterial blood pres ure and heart rate have
been reported following induction of light general anaesthesia
and administration of muscle relaxants. Further increases may
follow laryngoscopy and endotracheal intubation, even in the
absence of coughing, hypoxia and hypocarbia.3.9 Hypertension
during induction of anaesthesia in critically ill patients may be
harmful, causing cerebral haemorrhage, 10 left ventricular failure
and serious cardiac dysrhythmias. 11 .12 Hypertension is also
hazardous to patients with coronary artery disease, since myo-
cardial ischaemia may develop because of the increase in cardiac
work. None of the several methods that have been investigated in
an effort to attenuate the cardiovascular changes which occur
during endotracheal intubation have proved to be satisfactory.3-7
The use of topical lignocaine has shown that arterial blood
pressure increases significantly after application of a topical
anaesthetic to the larynx.3.5
The adverse cardiovascular responses to endotracheal intuba-
tion which have been described are allegedly mediated through
the sympathetic nervous system and therefore may in theory be
suppressed by adrenergic receptor blockade. The commonest
theoretical objection to adrenergic receptor blockade before
anaesthesia is that it impairs cardiac performance, and a number
of mechanisms have been implicated.
Labetalol, a recently developed adrenergic receptor antago-
nist, is unique in that it has the properties of a R-adrenergic
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blocking drug while possessing weak a-blocking potential as
well. These properties suggest that it would be the ideal agent to
attenuate the cardiovascular changes occurring on endotracheal
intubation.
While neither of the twO drugs tested succeeded in abolishing
the cardiovascular changes that follow direct laryngoscopy and
intubation the study has demonstrated some benefit in attenua-
ting detri~entalinc~eases in heart rate by the use ofJabetalol (in
both dosage ranges) and practolol.
It is more difficult to draw conclusions from the changes in
blood pressure that were observed. I t would appear that labetalol
in the higher dosage range (0,5 mg/kg) exerted the most benefi-
cial effects on the peak values of mean blood pressure (P = 0,14).
The lack of efficacy of practolol in attenuating the pressor
changes is probably due to the fact that the drug has partial
agonist activity at the R-adrenergic receptor site.
Of the three pretreatment regimens tested, we believe that
labetalol 0,5 mg/kg has been demonstrated to be ofsome benefit
in arrenuating detrimental rises in heart rate and blood pressure.
However, this dosage regimen, pracrolol (0,4 mg/kg) and low-
dose labetalol (0,25 mg/kg) do not seem to be the answer to the
problem of acute hypertension following endotracheal intuba-
tion. Studies ofa larger number of patients should be performed
to resolve the question of statistical significance.
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